Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 12623 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
0603U
|
Drug assay presumptive 77 drugs or metabolites urine liquid chromatography with tandem mass spectrometry (LC-MS/MS) results reported as positive or negative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0604U
|
Allergy and immunology (chronic recurrent angioedema) 4 bradykinin peptides liquid chromatography and tandem mass spectrometry (LC-MS/MS) whole blood quantitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0605U
|
Allergy and immunology (hereditary alpha tryptasemia) DNA analysis of TPSAB1 gene copy number variation using digital PCR whole blood results reported with genotype-specific interpretation of alpha-tryptase copy number and algorithmic classification as normal or abnormal
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0606U
|
Hematology (red cell membrane disorders) RBCs osmotic gradient ektacytometry whole blood quantitative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0607U
|
Reproductive medicine (endometrial microbiome assessment) real-time PCR analysis for 31 bacterial DNA targets from endometrial biopsy reported with quantified levels of bacterial presence and targeted treatment recommendations
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0608U
|
Reproductive medicine (endometrial microbiome assessment) real-time PCR analysis for 10 bacterial DNA targets from endometrial biopsy reported with quantified levels of bacterial presence and targeted treatment recommendations
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0609U
|
Oncology (prostate) immunoassay for total prostate-specific antigen (PSA) and free PSA serum or plasma combined with clinical features algorithm reported as a probability score for clinically significant prostate cancer
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0610U
|
Infectious disease (antimicrobial susceptibility) phenotypic antimicrobial susceptibility testing of positive blood culture using microfluidic sensor technology to quantify bacterial growth response to multiple antibiotic types reporting categorical susceptibility (susceptible susceptible dose dependent intermediate resistant) minimum inhibitory concentration and interpretive comments
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0611U
|
Oncology (liver) analysis of over 1000 methylated regions cell-free DNA from plasma algorithm reported as a quantitative result
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0612U
|
Oncology (liver) analysis of over 1000 methylated regions cell-free DNA from plasma algorithm reported as a quantitative result
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0613U
|
Oncology (urothelial carcinoma) DNA methylation and mutation analysis of 6 biomarkers (TWIST1 OTX1 ONECUT2 FGFR3 HRAS TERT promoter region) methylation-specific PCR and targeted next-generation sequencing urine algorithm reported as a probability index for bladder cancer and upper tract urothelial carcinoma
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0614U
|
Inborn error of metabolism (primary mitochondrial disease) mitochondrial analysis of 4 enzyme complexes by stained blue native polyacrylamide gel electrophoresis (PAGE) frozen tissue (muscle liver heart cultured skin fibroblasts) diagnostic qualitative result
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0615U
|
Borrelia burgdorferi (Lyme disease) antibody detection of 26 recombinant protein groups by immunoassay IgM
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0616T
|
Insertion of iris prosthesis including suture fixation and repair or removal of iris when performed; without removal of crystalline lens or intraocular lens without insertion of intraocular lens
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0616U
|
Neurology (dementia) DNA methylation analysis of more than 30000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0617T
|
Insertion of iris prosthesis including suture fixation and repair or removal of iris when performed; with removal of crystalline lens and insertion of intraocular lens
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0617U
|
Cardiovascular (atherosclerotic cardiovascular disease [ASCVD]) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0618T
|
Insertion of iris prosthesis including suture fixation and repair or removal of iris when performed; with secondary intraocular lens placement or intraocular lens exchange
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0618U
|
Psychiatry (bipolar disorder) DNA methylation analysis of more than 10000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0619T
|
Cystourethroscopy with transurethral anterior prostate commissurotomy and drug delivery including transrectal ultrasound and fluoroscopy when performed
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.